Meningococcal Vaccines Market 2025 - 2035

Reports - Meningococcal Vaccines Market

Healthcare

Meningococcal Vaccines Market

Meningococcal Vaccines Market Size Analysis Report 2025-2035 by Type (Polysaccharide Vaccines, Conjugate Vaccines, Combination Vaccines) by Age Group (Infants (0 to 2 Years), Children & Adults (2 Years & Above)) by Serotype (Serotype A, Serotype B, Serotype C, Serotype W-135, Serotype Y) by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others (Online Pharmacies, Drug Stores)) by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Request Sample Access TOC

Industry Leaders Trust Us For Actionable Intelligence

Revenue Insight View Inclusion

Chapter 1 Executive Dashboard

1. Strategic Imperatives

Chapter 2 Premium Insights

1. Top 3 Trends to Watch

2. Demand and Supply Trends

3. Top 3 Strategies Followed by Major Players

4. Top 3 Predictions by Vantage Market Research

5. Top Investment Pockets

6. Insights from Primary Respondents

Chapter 3 Global Meningococcal Vaccines Market - Segment Analysis

1. Overview

2. Global Meningococcal Vaccines Market, 2021 - 2035 (USD Million)

3. Global Meningococcal Vaccines Market - by Type

3.1. By Polysaccharide Vaccines

3.2. By Conjugate Vaccines

3.3. By Combination Vaccines

4. Global Meningococcal Vaccines Market - by Age Group

4.1. By Infants (0 to 2 Years)

4.2. By Children & Adults (2 Years & Above)

5. Global Meningococcal Vaccines Market - by Serotype

5.1. By Serotype A

5.2. By Serotype B

5.3. By Serotype C

5.4. By Serotype W-135

5.5. By Serotype Y

6. Global Meningococcal Vaccines Market - by Distribution Channel

6.1. By Hospital Pharmacies

6.2. By Retail Pharmacies

6.3. By Others (Online Pharmacies, Drug Stores)

7. Global Meningococcal Vaccines Market - by region

7.1. North America

7.2. Europe

7.3. Asia Pacific

7.4. Latin America

7.5. Middle East & Africa

8. Market comparative analysis

Chapter 4 North America Meningococcal Vaccines Market - Segment Analysis

1. Overview

2. North America Meningococcal Vaccines Market, 2021 - 2035 (USD Million)

3. North America Meningococcal Vaccines Market - by Type

3.1. By Polysaccharide Vaccines

3.2. By Conjugate Vaccines

3.3. By Combination Vaccines

4. North America Meningococcal Vaccines Market - by Age Group

4.1. By Infants (0 to 2 Years)

4.2. By Children & Adults (2 Years & Above)

5. North America Meningococcal Vaccines Market - by Serotype

5.1. By Serotype A

5.2. By Serotype B

5.3. By Serotype C

5.4. By Serotype W-135

5.5. By Serotype Y

6. North America Meningococcal Vaccines Market - by Distribution Channel

6.1. By Hospital Pharmacies

6.2. By Retail Pharmacies

6.3. By Others (Online Pharmacies, Drug Stores)

Chapter 5 Europe Meningococcal Vaccines Market - Segment Analysis

1. Overview

2. Europe Meningococcal Vaccines Market, 2021 - 2035 (USD Million)

3. Europe Meningococcal Vaccines Market - by Type

3.1. By Polysaccharide Vaccines

3.2. By Conjugate Vaccines

3.3. By Combination Vaccines

4. Europe Meningococcal Vaccines Market - by Age Group

4.1. By Infants (0 to 2 Years)

4.2. By Children & Adults (2 Years & Above)

5. Europe Meningococcal Vaccines Market - by Serotype

5.1. By Serotype A

5.2. By Serotype B

5.3. By Serotype C

5.4. By Serotype W-135

5.5. By Serotype Y

6. Europe Meningococcal Vaccines Market - by Distribution Channel

6.1. By Hospital Pharmacies

6.2. By Retail Pharmacies

6.3. By Others (Online Pharmacies, Drug Stores)

Chapter 6 Asia Pacific Meningococcal Vaccines Market - Segment Analysis

1. Overview

2. Asia Pacific Meningococcal Vaccines Market, 2021 - 2035 (USD Million)

3. Asia Pacific Meningococcal Vaccines Market - by Type

3.1. By Polysaccharide Vaccines

3.2. By Conjugate Vaccines

3.3. By Combination Vaccines

4. Asia Pacific Meningococcal Vaccines Market - by Age Group

4.1. By Infants (0 to 2 Years)

4.2. By Children & Adults (2 Years & Above)

5. Asia Pacific Meningococcal Vaccines Market - by Serotype

5.1. By Serotype A

5.2. By Serotype B

5.3. By Serotype C

5.4. By Serotype W-135

5.5. By Serotype Y

6. Asia Pacific Meningococcal Vaccines Market - by Distribution Channel

6.1. By Hospital Pharmacies

6.2. By Retail Pharmacies

6.3. By Others (Online Pharmacies, Drug Stores)

Chapter 7 Latin America Meningococcal Vaccines Market - Segment Analysis

1. Overview

2. Latin America Meningococcal Vaccines Market, 2021 - 2035 (USD Million)

3. Latin America Meningococcal Vaccines Market - by Type

3.1. By Polysaccharide Vaccines

3.2. By Conjugate Vaccines

3.3. By Combination Vaccines

4. Latin America Meningococcal Vaccines Market - by Age Group

4.1. By Infants (0 to 2 Years)

4.2. By Children & Adults (2 Years & Above)

5. Latin America Meningococcal Vaccines Market - by Serotype

5.1. By Serotype A

5.2. By Serotype B

5.3. By Serotype C

5.4. By Serotype W-135

5.5. By Serotype Y

6. Latin America Meningococcal Vaccines Market - by Distribution Channel

6.1. By Hospital Pharmacies

6.2. By Retail Pharmacies

6.3. By Others (Online Pharmacies, Drug Stores)

Chapter 8 Middle East & Africa Meningococcal Vaccines Market - Segment Analysis

1. Overview

2. Middle East & Africa Meningococcal Vaccines Market, 2021 - 2035 (USD Million)

3. Middle East & Africa Meningococcal Vaccines Market - by Type

3.1. By Polysaccharide Vaccines

3.2. By Conjugate Vaccines

3.3. By Combination Vaccines

4. Middle East & Africa Meningococcal Vaccines Market - by Age Group

4.1. By Infants (0 to 2 Years)

4.2. By Children & Adults (2 Years & Above)

5. Middle East & Africa Meningococcal Vaccines Market - by Serotype

5.1. By Serotype A

5.2. By Serotype B

5.3. By Serotype C

5.4. By Serotype W-135

5.5. By Serotype Y

6. Middle East & Africa Meningococcal Vaccines Market - by Distribution Channel

6.1. By Hospital Pharmacies

6.2. By Retail Pharmacies

6.3. By Others (Online Pharmacies, Drug Stores)

Chapter 9 Key Market Dynamics

1. Introduction

2. Market Drivers

3. Market Restraints

4. Market Opportunities

5. Porter's Five Forces Analysis

6. PEST Analysis

7. Regulatory Landscape

8. Technology Landscape

9. Regional Market Trends

Chapter 10 COVID 19 Impact Analysis

1. Key strategies undertaken by companies to tackle COVID-19

2. Short term dynamics

3. Long term dynamics

Chapter 11 Marketing Strategy Analysis

1. Marketing Channel

2. Direct Marketing

3. Indirect Marketing

4. Marketing Channel Development Trends

Chapter 12 Competitive Landscape

1. Competition Matrix - 2021

2. Company Market Share Analysis - 2021

3. Key Company Activities, 2018 - 2021

4. Strategic Developments - Heat Map Analysis

5. Company Offering Evaluation

6. Company Regional Presence Evaluation

Chapter 13 Company Profiles

1. Merck & Co. Inc. (U.S.)

2. Pfizer Inc. (U.S.)

3. Serum Institute of India Pvt. Ltd. (India)

4. Sanofi (France)

5. GSK PLC (UK)

6. Walvax Biotechnology Co. Ltd. (China)

7. Novartis AG (Switzerland)

8. Hualan Biological Engineering Inc. (China)

9. Incepta Pharmaceuticals Limited (Bangladesh)

10. Bio-Med (P) Limited (India)

Chapter 14 Key Primary Respondents - VERBATIM

Chapter 15 Discussion Guide

Chapter 16 Customization Offered

Chapter 17 Annexure

Chapter 18 List of Figures

Chapter 19 List of Tables

Chapter 20 List of Abbreviations

Customize your report

Cross-Segment Market Size And Analysis For Mentioned Segments

Additional Company Profiles (Upto 5 With No Cost)

Additional Countries (Apart From Mentioned Countries)

Country/Region-Specific Report

Go To Market Strategy

Region Specific Market Dynamics

Region Level Market Share

Import Export Analysis

Others

FAQ‘s

Related Reports

Healthcare

Canine Vaccines Market

Ganesh Palve

16 Oct 2024

5 Min Read

Canine Vaccines Market Size, Share & Trends Analysis Report by Types (Canine Distemper, Canine Parvovirus, Tracheobronchitis, Canine Coronavirus, Canine Leptospirosis)...

From $ 4999

Healthcare

Seasonal Influenza Vaccines Therapeutics Market

Mrudula Shah

16 Oct 2024

5 Min Read

Seasonal Influenza Vaccines Therapeutics Market Size, Share & Trends Analysis Report by Types (Paediatrics, Adolescence, Adults, Elderly) by Application (Hospitals,...

From $ 4999

Healthcare

Animal Vaccines Market

Mrudula Shah

25 Jul 2024

5 Min Read

Animal Vaccines Market Size, Share & Trends Analysis Report by Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines,...

From $ 4999

Healthcare

Meningococcal Vaccines Market

Mrudula Shah

29 May 2024

5 Min Read

Meningococcal Vaccines Market Size, Share & Trends Analysis Report by Type (Polysaccharide Vaccines, Conjugate Vaccines, Combination Vaccines) by Age Group...

From $ 4999

Healthcare

Therapeutic Vaccines Market

Ganesh Palve

15 Jan 2024

5 Min Read

Therapeutic Vaccines Market Size, Share & Trends Analysis Report by Product (Addiction Vaccines, Autoimmune Disease Vaccines, Neurological Disease Vaccines, Infectious...

From $ 4999

Vaccines Market

Vaccines Market Size, Share & Trends Analysis Report by Technology (excluding COVID 19 vaccines) (Conjugate vaccines, Inactivated & Subunit vaccines,...

From $ 4999

Company

About Us Services Contact Us Career

Quicklinks

How to order All reports Latest reports Upcoming reports Press Release Blogs

Support

Contact

US Office:

224 W 35th St Ste 500, New York, NY 10001, United States

India Office:

Kamdhenu Jasmine, Main Road, Pimple Saudagar, Pune, Maharashtra, 411027

+1 (212) 951-1369

Toll Free Number+1 (877) 462-2282

sales@vantagemarketresearch.com

Vantage Market Research & Consultancy Services is all about providing accurate and reliable market intelligence to its clients for the seamless execution of their business growth strategies.

Secured By

Meningococcal Vaccines Market

Table of Contents

Customize your report

FAQ‘s

Related Reports